web analytics
Pharmaceutical cGMP | cGMP Pharmaceutical Manufacturing | Drug Product Manufacturing

Pharmaceutical cGMP

cGMP Pharmaceutical Manufacturing

Velesco specializes in nimble, just-in-time (JIT) cGMP drug product pharmaceutical manufacturing as well as traditional pharmaceutical cGMP manufacturing. Read more about Velesco's nimblocity

 

JIT clinical supply manufacture offers several advantages over traditional pharmaceutical manufacturing, especially during dose escalation studies. Because clinical supplies can be manufactured just before drug dosing, there is no need for extensive stability studies, or the waste of drug substance for doses that are not reached in the clinic.

 

Featured Product: Hand filled softgel capsules for phase 1 clinical studies

 

Learn more about hand-filled softgel capsules

 

  • Semi-solids (non-sterile gels and creams)
  • Hand-filled softgel capsules
  • Powder in bottle
  • Powder in capsule - active pharmaceutical ingredient (API) in capsule
  • Simple blends in capsule
  • Non-sterile liquids (suspensions and solutions), scale up to 100 L
  • Over-encapsulation
  • Pharmaceutical packaging
  • Drug release

LORIE LANE 4

 

 

 LORIE LANE 1

 

 

 

 

News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!


Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!


Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.


In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.


Roundtable: M&A trends in CDMO - Molecule to Market


New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.


Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.


Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.


CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!


1 new job postings! Careers


Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.


Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100

734-274-9877